SPRB · NASDAQ
Spruce Biosciences (SPRB) Stock Price & Fundamentals
Spruce Biosciences (SPRB) closed at $503.43 on Oct 9, 2026, up 0.13% from the previous close of $502.78.
Share price, past year
1Y +0.71%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $503.43 |
| Sep 30, 2026 | $507.90 |
| Aug 31, 2026 | $539.05 |
| Jul 31, 2026 | $539.63 |
| Jun 30, 2026 | $507.44 |
| May 29, 2026 | $518.06 |
| Apr 30, 2026 | $523.55 |
| Mar 31, 2026 | $531.51 |
| Feb 27, 2026 | $551.36 |
| Jan 30, 2026 | $549.52 |
| Dec 31, 2025 | $550.36 |
| Nov 28, 2025 | $530.57 |
| Oct 31, 2025 | $508.11 |
Key statistics
- Market cap
- $1.39B
- P/E (TTM)
- —
- EPS (TTM)
- −$39.00
- Revenue (TTM)
- $0.00
- Net income (TTM)
- −$51.35M
- Shares outstanding
- 2.8M
- Dividend yield
- —
- 52-week range
- $490.83 – $575.14
Spruce Biosciences's market cap is $1.39B, based on a share price of $503.43 and 2.8M shares outstanding as of Jun 30, 2026.
Financials
Spruce Biosciences reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Spruce Biosciences reported a net loss of $38.97M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | −100.0% | −$38.97M | — | −$50.83 | — |
| FY2024ended Dec 31, 2024 | $4.91M | −51.3% | −$53.04M | −1,079.9% | −$96.40 | −$55.96M |
| FY2023ended Dec 31, 2023 | $10.09M | — | −$47.92M | −475.0% | −$1.24 | −$33.28M |
| FY2022ended Dec 31, 2022 | $0.00 | — | −$46.18M | — | −$1.96 | −$41.69M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2025ended Dec 31, 2025 | $0.00 | −$14.65M | −$8.80 |
| Q3 FY2025ended Sep 30, 2025 | $0.00 | −$8.21M | −$14.58 |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$2.07M | −$3.50 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$14.04M | −$23.95 |
| Q4 FY2024ended Dec 31, 2024 | $697.00K | −$23.56M | −$63.64 |
| Q3 FY2024ended Sep 30, 2024 | $602.00K | −$8.67M | −$15.75 |
| Q2 FY2024ended Jun 30, 2024 | $1.61M | — | — |
| Q1 FY2024ended Mar 31, 2024 | $2.00M | — | — |
Company profile
- Name
- Spruce Biosciences, Inc.
- Ticker
- SPRB
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 611 Gateway Boulevard, Suite 740, South San Francisco, CA 94080
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001683553
Recent SEC filings
- Aug 12, 2026
- Aug 12, 2026
- Jul 27, 2026
- May 26, 2026
- May 13, 2026
- May 13, 2026
- Apr 22, 2026
- Mar 20, 2026
Frequently asked questions
What is Spruce Biosciences's stock price?
Spruce Biosciences (SPRB) closed at $503.43 on Oct 9, 2026, up 0.13% from the previous close of $502.78.
What is Spruce Biosciences's market cap?
Spruce Biosciences's market cap is $1.39B, based on a share price of $503.43 and 2.8M shares outstanding as of Jun 30, 2026.
How much revenue does Spruce Biosciences make?
Spruce Biosciences reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Does Spruce Biosciences pay a dividend?
Spruce Biosciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Spruce Biosciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures